August 25, 2026
Bonus Content: Who Wins When the Referee Blows the Whistle on Hedge Fund Leverage?
In the 1800s, John D. Rockefeller started refining oil into the world’s most valuable fuel. Now, another innovator is creating its own “Rockefeller Moment” with one of the world’s most abundant energy resources: coal.
This is more important than ever right now, because a perfect storm of operational breakthroughs and policy shifts has the potential to directly impact this company’s valuation.
What’s creating this “Rockefeller Moment” for coal?
Using their patented FASForm technology, Frontieras can transform coal into high-value commodities like diesel and jet fuel without burning it.
They’re targeting a $2.1 trillion total addressable market where demand for these commodities is virtually unlimited.
Reaching just 2% of the global coal market could position Frontieras as a major leader in the space.
That’s why the institutional investors are already moving. Frontieras has secured a $150 million investment commitment from GEM and raised over $50 million from private investors.
But here’s why 2026 is shaping up to be such a historic year for this company:
- NASDAQ ticker reserved: Frontieras has officially reserved the “FASF” ticker, a major step toward a public listing.
- The “Big Beautiful Bill”: Under a White House that favors domestic energy, Frontieras is positioned for rapid scale.
- Real-world infrastructure: Frontieras just broke ground on their $850 million flagship facility in Mason County, West Virginia.
Frontieras is creating what could be a pivotal moment for the future of energy on the world stage.
Don’t miss your chance to become a Frontieras shareholder. The opportunity closes on August 27.
Who Wins When the Referee Blows the Whistle on Hedge Fund Leverage?
Hey there, bargain hunter. While most of Wall Street is watching whether $6.6 trillion in leveraged Treasury positions unwinds cleanly, there is a quieter question worth your attention: who collects the toll no matter what happens? The answer is sitting in plain sight, and it trades on a publicly quoted exchange.
Scoreboard
The 30-year Treasury yield hit 5.33% in mid-August, its highest since April 2007. The US Treasury then auctioned $25 billion in 30-year bonds at a yield of 5.216%, the steepest auction rate since 2001. Meanwhile, CME stock rose 1.92% in a single session last Friday, adding roughly $1.9 billion in market cap on the back of bond-market turbulence alone. Analysts’ average price target sits at $283, implying only about 3% further upside from Friday’s close. That gap between the business momentum and the consensus estimate is where this conversation gets interesting.
The Real Reason
Two forces are colliding. First, the leverage itself. A June 22 Federal Reserve research note found that large hedge funds carry gross US Treasury exposure of roughly $4.0 trillion. On February 4, the FSB’s repo market report estimated $16 trillion in government bond-backed repo outstanding at end-2024, and warned that leverage, demand-supply imbalances, and high concentration all have the potential to strain the system. The Bank of England’s July 2026 Financial Stability Report added that a significant rise in hedge fund leverage is creating risks via prime brokers and through markets interconnected by hedge funds’ exposures, specifically naming sovereign debt.
Second, and less discussed: the buyers who used to absorb long-dated supply are stepping back. Fed custody data showed foreign official Treasury holdings dropping $100 billion since April to the lowest levels of the year. The Institute of International Finance reported in May that net purchases of US government debt by foreign investors have been flat in 2026, even as Japanese and European sovereign paper has attracted increased accumulation. When the traditional anchor buyers shrink, price-sensitive buyers fill the gap. Price-sensitive buyers hedge. Hedging means volume for exchanges.
The Business Nobody Talks About
CME Group holds roughly a 90% market share in US Treasury futures, runs a 63% net profit margin, and posted average daily volume of 36.2 million contracts in Q1 2026. Two-year Treasury options volume was up 92% through July. The company is not a bet on whether the basis trade unwinds gracefully. It is a bet on volatility and volume regardless of direction.
ICE is the other side of the same coin, with record FY25 results: net revenues up 7%, operating income up about 14%, and adjusted diluted EPS up 14%.
Neither firm is cheap on a trailing multiple. CME was trading near $255 in late July at roughly 21x trailing earnings. But the multiple calculation changes materially if you include what regulation is about to deliver.
The Mandatory Volume Catalyst
The SEC’s mandatory clearing rules take effect December 31, 2026 for eligible cash Treasuries, with repo following June 30, 2027. The DTCC estimates the mandate will move an additional $4 trillion in daily transaction volume into central clearing. CME Securities Clearing and ICE Clear Credit both received SEC approval for Treasury clearing services, with ICE describing its Treasury clearing service as operationally live. That is not speculative volume. It is mandated volume.
The FSB explicitly called for closing data gaps and curbing leverage through stronger standards. If regulators follow through with margin or haircut requirements, the basis trade either gets smaller or gets more expensive to run, which means more hedging activity routed through futures and cleared instruments. Either outcome lifts CME’s and ICE’s addressable market.
Bull / Base / Bear
- Bull: Mandatory clearing drives a structural, durable step-up in cleared volume. Volatility stays elevated. CME’s 63% margin means most of that incremental revenue falls to the bottom line.
- Base: Volume beats consensus modestly. The clearing mandate goes live without delay. Stocks grind higher with earnings rather than through multiple expansion.
- Bear: Congress or the SEC delays or weakens the clearing mandate. A forced unwind in the basis trade briefly stresses CME’s clearing infrastructure, triggering regulatory scrutiny. The stock de-rates.
Action Plan
CME at ~$255 is not a screaming value, but it is a regulated toll road with a government-mandated volume expansion arriving by December 31. A starter position now, with a second tranche if the stock pulls back toward the $230 range on a broader risk-off move, gives you a reasonable entry ladder. ICE near $140 is the diversified version: you get the clearing catalyst plus a mortgage-tech and data business that is less correlated to rate volatility.
Trim territory is above consensus, around $290 for CME, unless the clearing volumes come in well above the $4 trillion per day estimate.
Cheap Investor Checklist
- Did CME’s Treasury clearing service go live before December 31, 2026?
- Is post-mandate daily cleared volume tracking toward the DTCC’s $4 trillion estimate?
- Are FSB or Fed haircut/margin rules tightening, pushing more hedging into listed futures?
- Is CME’s net profit margin holding above 60%?
- Is foreign official Treasury demand still declining, sustaining price-sensitive buyer activity?
- Did the 30-year yield stay above 5%, keeping hedging demand structurally elevated?
- Is ICE EPS growth tracking its FY25 pace into 2026?
- Any signs of regulatory delay to the December 2026 clearing mandate?
Bottom Line
If regulators mean what they have spent all of 2026 saying, CME and ICE are not just beneficiaries of volatility. They are the mandated infrastructure for a market that is being forced to clean up its leverage. That is worth paying a modest premium for. The question is whether the current multiple already bakes it in. At ~21x earnings, with $4 trillion in mandatory daily volume not yet in the run rate, the answer is probably not yet.
